cetylpyridinium chloride anhydrous has been researched along with desogestrel in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ory, HW | 1 |
4 other study(ies) available for cetylpyridinium chloride anhydrous and desogestrel
Article | Year |
---|---|
Pill research results in new guidance from CSM.
Topics: Biology; Communication; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Demography; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Geography; Health; Health Personnel; Knowledge; Levonorgestrel; Norethindrone; Population; Public Health; Residence Characteristics; Risk Assessment; Risk Factors; Safety; Thromboembolism; Thrombosis; United Kingdom; Vascular Diseases | 1995 |
Epidemiology of venous thromboembolic disease and OC use.
Topics: Bias; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Disease; Embolism; Epidemiology; Family Planning Services; Health; Public Health; Research; Research Design; Risk Factors; Thromboembolism; Vascular Diseases | 1996 |
Warnings on venous thromboembolism risks may have been premature. New data may lead to change in use of third-generation OCs.
Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Developed Countries; Disease; Embolism; England; Europe; Family Planning Services; Health; Public Health; Risk Factors; Safety; Thromboembolism; United Kingdom; Vascular Diseases | 1997 |
2 methods for prescribing third-generation OCs.
Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Desogestrel; Developed Countries; Disease; Drug Prescriptions; Embolism; Europe; Family Planning Services; Health; Health Personnel; Health Planning; Health Planning Guidelines; Organization and Administration; Physicians; Public Health; Risk Factors; Safety; Thromboembolism; United Kingdom; Vascular Diseases | 1997 |